Kara Cannon - 23 Nov 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZB)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENZ	Stock Option (to acquire Common Stock)	Award	$0	+200,000	$0.000000	200,000	23 Nov 2022	Common Stock	200,000	$1.97	Direct	F1
holding	ENZ	Stock Option (to acquire Common Stock)					87,500	23 Nov 2022	Common Stock	87,500	$2.98	Direct	F2
holding	ENZ	Stock Option (to acquire Common Stock)					87,500	23 Nov 2022	Common Stock	87,500	$3.36	Direct	F2
holding	ENZ	Stock Option (to acquire Common Stock)					55,400	23 Nov 2022	Common Stock	55,400	$2.63	Direct	F2
holding	ENZ	Stock Option (to acquire Common Stock)					55,400	23 Nov 2022	Common Stock	55,400	$2.20	Direct	F2
holding	ENZ	Stock Option (to acquire Common Stock)					52,000	23 Nov 2022	Common Stock	52,000	$2.80	Direct	F2
holding	ENZ	Stock Option (to acquire Common Stock)					35,000	23 Nov 2022	Common Stock	35,000	$4.42	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The Reporting Person was granted 200,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 23, 2023.
F2	The stock options have a five-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.